Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway
出版年份 2023 全文链接
标题
Protein-protein interactions and related inhibitors involved in the NLRP3 inflammasome pathway
作者
关键词
-
出版物
CYTOKINE & GROWTH FACTOR REVIEWS
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-09-16
DOI
10.1016/j.cytogfr.2023.09.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- TXNIP inhibition in the treatment of type 2 diabetes mellitus: design, synthesis, and biological evaluation of quinazoline derivatives
- (2023) Aiyun Li et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction
- (2023) Qiang Ma PHARMACOLOGICAL REVIEWS
- Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation
- (2023) Jianing Fu et al. Annual Review of Immunology
- A Review of RRx-001: A Late-Stage Multi-Indication Inhibitor of NLRP3 Activation and Chronic Inflammation
- (2023) Nanthini Jayabalan et al. DRUGS
- Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
- (2023) Ju-Hui Kang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer
- (2023) Valentina Albanese et al. Journal of Medicinal Chemistry
- Structure of the NLRP3 decamer bound to the cytokine release inhibitor CRID3
- (2022) Inga V. Hochheiser et al. NATURE
- Structural basis for the oligomerization-mediated regulation of NLRP3 inflammasome activation
- (2022) Umeharu Ohto et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- N-Lobe of TXNIP Is Critical in the Allosteric Regulation of NLRP3 via TXNIP Binding
- (2022) Fengyu Cheng et al. Frontiers in Aging Neuroscience
- Directionality of PYD filament growth determined by the transition of NLRP3 nucleation seeds to ASC elongation
- (2022) Inga V. Hochheiser et al. Science Advances
- RRx-001 and the “Right stuff”: Protection and treatment in outer space
- (2022) Bryan Oronsky et al. Life Sciences in Space Research
- The NLRP3 Inflammasome Pathway: A Review of Mechanisms and Inhibitors for the Treatment of Inflammatory Diseases
- (2022) Hallie M. Blevins et al. Frontiers in Aging Neuroscience
- Probing the effect of NEK7 and cofactor interactions on dynamics of NLRP3 monomer using molecular simulation
- (2022) Sherihan El‐Sayed et al. PROTEIN SCIENCE
- Caveolin-1 ameliorates acetaminophen-aggravated inflammatory damage and lipid deposition in non-alcoholic fatty liver disease via the ROS/TXNIP/NLRP3 pathway
- (2022) Xiangfu Jiang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The leucine-rich repeat (LRR) domain of NLRP3 is required for NLRP3 inflammasome activation in macrophages
- (2022) Yanhui Duan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Overcoming Preclinical Safety Obstacles to Discover (S)-N-((1,2,3,5,6,7-Hexahydro-s-indacen-4-yl)carbamoyl)-6-(methylamino)-6,7-dihydro-5H-pyrazolo[5,1-b][1,3]oxazine-3-sulfonamide (GDC-2394): A Potent and Selective NLRP3 Inhibitor
- (2022) Christopher McBride et al. Journal of Medicinal Chemistry
- Cryo-EM structures of the active NLRP3 inflammasome disc
- (2022) Le Xiao et al. NATURE
- Distinct changes in endosomal composition promote NLRP3 inflammasome activation
- (2022) Zhirong Zhang et al. NATURE IMMUNOLOGY
- The NLRP3 inflammasome in depression: Potential mechanisms and therapies
- (2022) Cong-Yuan Xia et al. PHARMACOLOGICAL RESEARCH
- The NLRP3 inflammasome: activation and regulation
- (2022) Jie Xu et al. TRENDS IN BIOCHEMICAL SCIENCES
- Targeting the TXNIP‐NLRP3 interaction with PSSM1443 to suppress inflammation in sepsis‐induced myocardial dysfunction
- (2021) Linhua Wang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- NLRP3 inflammasome in cancer and metabolic diseases
- (2021) Bhesh Raj Sharma et al. NATURE IMMUNOLOGY
- RRx-001 ameliorates inflammatory diseases by acting as a potent covalent NLRP3 inhibitor
- (2021) Yun Chen et al. Cellular & Molecular Immunology
- Sensing low intracellular potassium by NLRP3 results in a stable open structure that promotes inflammasome activation
- (2021) Ana Tapia-Abellán et al. Science Advances
- NLRP3 cages revealed by full-length mouse NLRP3 structure control pathway activation
- (2021) Liudmila Andreeva et al. CELL
- Alantolactone: A sesquiterpene lactone with diverse pharmacological effects
- (2021) Xin Liu et al. Chemical Biology & Drug Design
- Licochalcone B specifically inhibits the NLRP3 inflammasome by disrupting NEK7‐NLRP3 interaction
- (2021) Qiang Li et al. EMBO REPORTS
- Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition
- (2021) Carien Dekker et al. JOURNAL OF MOLECULAR BIOLOGY
- NLRP3 phosphorylation in its LRR domain critically regulates inflammasome assembly
- (2021) Tingting Niu et al. Nature Communications
- A Comprehensive Review for Phytochemical, Pharmacological, and Biosynthesis Studies on Glycyrrhiza spp.
- (2020) Chengcheng Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- Toward targeting inflammasomes: insights into their regulation and activation
- (2020) Shelbi Christgen et al. CELL RESEARCH
- Oridonin inhibits the migration and epithelial‐to‐mesenchymal transition of small cell lung cancer cells by suppressing FAK‐ERK1/2 signalling pathway
- (2020) Linhao Xu et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- STAT3 Inhibitor ODZ10117 Suppresses Glioblastoma Malignancy and Prolongs Survival in a Glioblastoma Xenograft Model
- (2020) Byung-Hak Kim et al. Cells
- Identification of an Anti-diabetic, Orally Available Small Molecule that Regulates TXNIP Expression and Glucagon Action
- (2020) Lance A. Thielen et al. Cell Metabolism
- Selective inhibition of NLRP3 inflammasome by designed peptide originating from ASC
- (2020) Petra Sušjan et al. FASEB JOURNAL
- Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity
- (2020) Qingxuan Zeng et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thioredoxin-Interacting Protein (TXNIP) Associated NLRP3 Inflammasome Activation in Human Alzheimer’s Disease Brain
- (2019) Lexiao Li et al. JOURNAL OF ALZHEIMERS DISEASE
- MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition
- (2019) Rebecca C. Coll et al. Nature Chemical Biology
- MCC950 closes the active conformation of NLRP3 to an inactive state
- (2019) Ana Tapia-Abellán et al. Nature Chemical Biology
- RRx-001 followed by platinum plus etoposide in patients with previously treated small-cell lung cancer
- (2019) Daniel Morgensztern et al. BRITISH JOURNAL OF CANCER
- Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways
- (2019) Huahong Yang et al. Cell Communication and Signaling
- Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
- (2019) Humayun Sharif et al. NATURE
- Anti-Neuroinflammatory Effect of Alantolactone through the Suppression of the NF-κB and MAPK Signaling Pathways
- (2019) Tan et al. Cells
- REPLATINUM Phase III randomized study: RRx-001 + platinum doublet versus platinum doublet in third-line small cell lung cancer
- (2019) Bryan Oronsky et al. Future Oncology
- Inflammasome-Mediated Inflammation in Liver Ischemia-Reperfusion Injury
- (2019) Mónica B. Jiménez-Castro et al. Cells
- Oridonin enhances TRAIL-induced apoptosis through GALNT14-mediated DR5 glycosylation
- (2019) Mi-Yeon Jeon et al. BIOCHIMIE
- Oridonin, A natural diterpenoid, protected NGF-differentiated PC12 cells against MPP+- and kainic acid-induced injury
- (2019) Kuan-Ho Lin et al. FOOD AND CHEMICAL TOXICOLOGY
- Protective Effects of Oridonin on Intestinal Epithelial Cells by Suppressing TNFα-Induced Inflammation and Epithelial-Mesenchymal Transition
- (2019) Claire Cummins et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Recent Progress of Oridonin and Its Derivatives for the Treatment of Acute Myelogenous Leukemia
- (2019) Xu Hu et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Development of Oxadiazole-Based ODZ10117 as a Small-Molecule Inhibitor of STAT3 for Targeted Cancer Therapy
- (2019) Kim et al. Journal of Clinical Medicine
- Development of small molecule inhibitors targeting NLRP3 inflammasome pathway for inflammatory diseases
- (2019) Xiangna Zhang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Dl-3-n-Butylphthalide Inhibits NLRP3 Inflammasome and Mitigates Alzheimer's-Like Pathology via Nrf2-TXNIP-TrX Axis
- (2018) Chun-Yan Wang et al. ANTIOXIDANTS & REDOX SIGNALING
- Tranilast directly targets NLRP3 to treat inflammasome‐driven diseases
- (2018) Yi Huang et al. EMBO Molecular Medicine
- Synthesis and biological evaluation of new berberine derivatives as cancer immunotherapy agents through targeting IDO1
- (2018) Yan–Xiang Wang et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Suppressive effects of berberine on atherosclerosis via downregulating visfatin expression and attenuating visfatin-induced endothelial dysfunction
- (2018) Qiang Wan et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Targeting the NLRP3 inflammasome in inflammatory diseases
- (2018) Matthew S. J. Mangan et al. NATURE REVIEWS DRUG DISCOVERY
- Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity
- (2018) Hongbin He et al. Nature Communications
- Identification of a fish-specific NOD-like receptor subfamily C (NLRC) gene from common carp (Cyprinus carpio L.): Characterization, ontogeny and expression analysis in response to immune stimulation
- (2018) Ting Li et al. FISH & SHELLFISH IMMUNOLOGY
- Chloride regulates dynamic NLRP3-dependent ASC oligomerization and inflammasome priming
- (2018) Jack P. Green et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cholesterol Homeostatic Regulator SCAP-SREBP2 Integrates NLRP3 Inflammasome Activation and Cholesterol Biosynthetic Signaling in Macrophages
- (2018) Chuansheng Guo et al. IMMUNITY
- PtdIns4P on dispersed trans-Golgi network mediates NLRP3 inflammasome activation
- (2018) Jueqi Chen et al. NATURE
- NLRP3 lacking the leucine-rich repeat domain can be fully activated via the canonical inflammasome pathway
- (2018) Iva Hafner-Bratkovič et al. Nature Communications
- The anti-tumor diterpene oridonin is a direct inhibitor of Nucleolin in cancer cells
- (2018) Michele Vasaturo et al. Scientific Reports
- Berberine, an isoquinoline alkaloid suppresses TXNIP mediated NLRP3 inflammasome activation in MSU crystal stimulated RAW 264.7 macrophages through the upregulation of Nrf2 transcription factor and alleviates MSU crystal induced inflammation in rats
- (2017) Palani Dinesh et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Berberine suppresses LPS-induced inflammation through modulating Sirt1/NF-κB signaling pathway in RAW264.7 cells
- (2017) Hao Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Vascular endothelial cells senescence is associated with NOD-like receptor family pyrin domain-containing 3 (NLRP3) inflammasome activation via reactive oxygen species (ROS)/thioredoxin-interacting protein (TXNIP) pathway
- (2017) Yanlin Yin et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice
- (2017) Auvro R. Mridha et al. JOURNAL OF HEPATOLOGY
- Synthesis and Identification of Novel Berberine Derivatives as Potent Inhibitors against TNF-α-Induced NF-κB Activation
- (2017) Yan-Xiang Wang et al. MOLECULES
- Oridonin attenuates the release of pro-inflammatory cytokines in lipopolysaccharide-induced RAW264.7 cells and acute lung injury
- (2017) Gan Zhao et al. Oncotarget
- NLRP3 inflammasome as a target of berberine in experimental murine liver injury: interference with P2X7 signalling
- (2016) E. Vivoli et al. CLINICAL SCIENCE
- RRx-001: a systemically non-toxic M2-to-M1 macrophage stimulating and prosensitizing agent in Phase II clinical trials
- (2016) Bryan Oronsky et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Cholesterol Accumulation in CD11c + Immune Cells Is a Causal and Targetable Factor in Autoimmune Disease
- (2016) Ayaka Ito et al. IMMUNITY
- Protective effects of oridonin on the sepsis in mice
- (2016) Yan-Jun Zhao et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Antitumor and Antibacterial Derivatives of Oridonin: A Main Composition of Dong-Ling-Cao
- (2016) Dahong Li et al. MOLECULES
- NEK7 is an essential mediator of NLRP3 activation downstream of potassium efflux
- (2016) Yuan He et al. NATURE
- Whole Brain Radiotherapy and RRx-001: Two Partial Responses in Radioresistant Melanoma Brain Metastases from a Phase I/II Clinical Trial
- (2016) Michelle M. Kim et al. Translational Oncology
- ASC filament formation serves as a signal amplification mechanism for inflammasomes
- (2016) Mathias S. Dick et al. Nature Communications
- Structure and evolutionary history of a large family of NLR proteins in the zebrafish
- (2016) Kerstin Howe et al. Open Biology
- Daphnetin Protects against Cerebral Ischemia/Reperfusion Injury in Mice via Inhibition of TLR4/NF-κB Signaling Pathway
- (2016) Jia Liu et al. Biomed Research International
- O3.8 * Early Results: "ROCKET" a phase II Study of RRx-001, a novel triple epigenetic inhibitor, Resensitization to Irinotecan in Colorectal Cancer
- (2015) C. Carter et al. ANNALS OF ONCOLOGY
- Inhibiting the Inflammasome: A Chemical Perspective
- (2015) Alex G. Baldwin et al. JOURNAL OF MEDICINAL CHEMISTRY
- NLRP3 activation and mitosis are mutually exclusive events coordinated by NEK7, a new inflammasome component
- (2015) Hexin Shi et al. NATURE IMMUNOLOGY
- A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
- (2015) Rebecca C Coll et al. NATURE MEDICINE
- Tranilast: A review of its therapeutic applications
- (2015) Sara Darakhshan et al. PHARMACOLOGICAL RESEARCH
- TXNIP mediates NLRP3 inflammasome activation in cardiac microvascular endothelial cells as a novel mechanism in myocardial ischemia/reperfusion injury
- (2014) Yi Liu et al. BASIC RESEARCH IN CARDIOLOGY
- Thioredoxin-interacting protein mediates NALP3 inflammasome activation in podocytes during diabetic nephropathy
- (2014) Pan Gao et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Unified Polymerization Mechanism for the Assembly of ASC-Dependent Inflammasomes
- (2014) Alvin Lu et al. CELL
- Mechanisms and Functions of Inflammasomes
- (2014) Mohamed Lamkanfi et al. CELL
- NLRP3 inflammasome activation is required for fibrosis development in NAFLD
- (2014) Alexander Wree et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Thioredoxin-Interacting Protein: a Novel Target for Neuroprotection in Experimental Thromboembolic Stroke in Mice
- (2014) Tauheed Ishrat et al. MOLECULAR NEUROBIOLOGY
- Antioxidant and anti-inflammatory activities of six flavonoids separated from licorice
- (2013) Yu Fu et al. FOOD CHEMISTRY
- K+ Efflux Is the Common Trigger of NLRP3 Inflammasome Activation by Bacterial Toxins and Particulate Matter
- (2013) Raúl Muñoz-Planillo et al. IMMUNITY
- Oridonin suppresses transplant rejection by depleting T cells from the periphery
- (2013) Wenzhi Guo et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Learning from berberine: Treating chronic diseases through multiple targets
- (2013) Jing Yao et al. Science China-Life Sciences
- Treating inflammation by blocking interleukin-1 in humans
- (2013) Charles A. Dinarello et al. SEMINARS IN IMMUNOLOGY
- Sweeten PAMPs: role of sugar complexed PAMPs in innate immunity and vaccine biology
- (2013) Ranjeet Singh Mahla Frontiers in Immunology
- IRE1α Induces Thioredoxin-Interacting Protein to Activate the NLRP3 Inflammasome and Promote Programmed Cell Death under Irremediable ER Stress
- (2012) Alana G. Lerner et al. Cell Metabolism
- Pharmacokinetic and Pharmacodynamic Properties of Canakinumab, a Human Anti-Interleukin-1β Monoclonal Antibody
- (2012) Abhijit Chakraborty et al. CLINICAL PHARMACOKINETICS
- Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
- (2012) Charles A. Dinarello et al. NATURE REVIEWS DRUG DISCOVERY
- NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis
- (2012) M. Inoue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Critical role for calcium mobilization in activation of the NLRP3 inflammasome
- (2012) T. Murakami et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Two-year results from an open-label, multicentre, phase III study evaluating the safety and efficacy of canakinumab in patients with cryopyrin-associated periodic syndrome across different severity phenotypes
- (2011) J. B. Kuemmerle-Deschner et al. ANNALS OF THE RHEUMATIC DISEASES
- Thioredoxin Interacting Protein: Redox Dependent and Independent Regulatory Mechanisms
- (2011) Oded N. Spindel et al. ANTIOXIDANTS & REDOX SIGNALING
- Stimulation of suicidal erythrocyte death by oridonin
- (2011) Kashif Jilani et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- Inhibition of SREBP by a Small Molecule, Betulin, Improves Hyperlipidemia and Insulin Resistance and Reduces Atherosclerotic Plaques
- (2011) Jing-Jie Tang et al. Cell Metabolism
- The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register
- (2011) J. B. Galloway et al. RHEUMATOLOGY
- Role of the leucine-rich repeat (LRR) domain of cryopyrin/NALP3 in monosodium urate crystal-induced inflammation
- (2010) Hal M. Hoffman et al. ARTHRITIS AND RHEUMATISM
- Differential Requirement for Caspase-1 Autoproteolysis in Pathogen-Induced Cell Death and Cytokine Processing
- (2010) Petr Broz et al. Cell Host & Microbe
- Intravenous Anakinra can Achieve Experimentally Effective Concentrations in the Central Nervous System within a Therapeutic Time Window: Results of a Dose-Ranging Study
- (2010) James Galea et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- The serum and cerebrospinal fluid pharmacokinetics of anakinra after intravenous administration to non-human primates
- (2010) Elizabeth Fox et al. JOURNAL OF NEUROIMMUNOLOGY
- A role for mitochondria in NLRP3 inflammasome activation
- (2010) Rongbin Zhou et al. NATURE
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals
- (2010) Peter Duewell et al. NATURE
- Nek7 kinase targeting leads to early mortality, cytokinesis disturbance and polyploidy
- (2010) H Salem et al. ONCOGENE
- Multiple-modulation effects of Oridonin on the production of proinflammatory cytokines and neurotrophic factors in LPS-activated microglia
- (2009) Yan Xu et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- The Nek6 and Nek7 Protein Kinases Are Required for Robust Mitotic Spindle Formation and Cytokinesis
- (2009) L. O'Regan et al. MOLECULAR AND CELLULAR BIOLOGY
- Thioredoxin-interacting protein links oxidative stress to inflammasome activation
- (2009) Rongbin Zhou et al. NATURE IMMUNOLOGY
- Risk of serious infections during rituximab, abatacept and anakinra treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials
- (2008) C Salliot et al. ANNALS OF THE RHEUMATIC DISEASES
- A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome
- (2008) Raphaela Goldbach-Mansky et al. ARTHRITIS AND RHEUMATISM
- A genomic view of the NOD-like receptor family in teleost fish: identification of a novel NLR subfamily in zebrafish
- (2008) Kerry J Laing et al. BMC EVOLUTIONARY BIOLOGY
- Protein networks in disease
- (2008) T. Ideker et al. GENOME RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now